Literature DB >> 11993178

[Middle meningeal artery embolization for refractory chronic subdural hematoma: 3 case reports].

Kazuya Takahashi1, Kenichiro Muraoka, Tomoyuki Sugiura, Yasuhiko Maeda, Shinya Mandai, Yuji Gohda, Masamitsu Kawauchi, Yuzo Matsumoto.   

Abstract

The authors present three cases of refractory chronic subdural hematoma (CSDH) treated by embolization of the middle meningeal artery (MMA) after several unsuccessful drainage procedures. The patients were initially treated by the usual method of burr hole and irrigation of the hematoma. After recurrence, several percutaneous puncture and drainage procedures were unable to prevent re-collection of the hematoma. Then the authors embolized the MMA which was thought to be the feeding artery of the outer membrane of the hematoma cavity. No enlargement of the hematoma was seen after embolization and, gradually, complete resolution of the hematoma was obtained. The outcome of the patients was excellent in all three cases. This new therapeutic approach to recurrent CSDH is discussed.

Entities:  

Mesh:

Year:  2002        PMID: 11993178

Source DB:  PubMed          Journal:  No Shinkei Geka        ISSN: 0301-2603


  11 in total

1.  Experience in endovascular treatment of recurrent chronic subdural hematoma.

Authors:  H Ishihara; S Ishihara; S Kohyama; F Yamane; M Ogawa; A Sato; M Matsutani
Journal:  Interv Neuroradiol       Date:  2007-06-27       Impact factor: 1.610

2.  A case of non-traumatic subgaleal hematoma effectively treated with endovascular surgery.

Authors:  K Koizumi; S Suzuki; S Utsuki; K Nakahara; J Niki; I Mabuchi; A Kurata; K Fujii
Journal:  Interv Neuroradiol       Date:  2010-10-25       Impact factor: 1.610

3.  Middle Meningeal Artery Embolization in Recurrent Chronic Subdural Hematoma Combined with Arachnoid Cyst.

Authors:  Jiin Kang; Kum Whang; Soon-Ki Hong; Jin-Soo Pyen; Sung-Min Cho; Jong-Yeon Kim; So-Hyun Kim; Ji-Woong Oh
Journal:  Korean J Neurotrauma       Date:  2015-10-31

Review 4.  Usefulness of interventional embolization of the middle meningeal artery for recurrent chronic subdural hematoma: Five cases and a review of the literature.

Authors:  Akira Tempaku; Shigeru Yamauchi; Hidetoshi Ikeda; Nobuyuki Tsubota; Hironori Furukawa; Daisuke Maeda; Kimito Kondo; Akimasa Nishio
Journal:  Interv Neuroradiol       Date:  2015-05-26       Impact factor: 1.610

5.  Embolization of the Middle Meningeal Artery for Refractory Chronic Subdural Haematoma. Usefulness for Patients under Anticoagulant Therapy.

Authors:  S Hirai; J Ono; M Odaki; T Serizawa; O Nagano
Journal:  Interv Neuroradiol       Date:  2008-05-15       Impact factor: 1.610

Review 6.  The surgical management of chronic subdural hematoma.

Authors:  Andrew F Ducruet; Bartosz T Grobelny; Brad E Zacharia; Zachary L Hickman; Peter L DeRosa; Kristen N Andersen; Kristen Anderson; Eric Sussman; Austin Carpenter; E Sander Connolly
Journal:  Neurosurg Rev       Date:  2011-09-10       Impact factor: 3.042

Review 7.  Clinical importance of the middle meningeal artery: A review of the literature.

Authors:  Jinlu Yu; Yunbao Guo; Baofeng Xu; Kan Xu
Journal:  Int J Med Sci       Date:  2016-10-17       Impact factor: 3.738

8.  Recurrence of a Refractory Chronic Subdural Hematoma after Middle Meningeal Artery Embolization That Required Craniotomy.

Authors:  Hideo Chihara; Hirotoshi Imamura; Takenori Ogura; Hidemitsu Adachi; Yukihiro Imai; Nobuyuki Sakai
Journal:  NMC Case Rep J       Date:  2014-05-09

9.  Usefulness of embolization of the middle meningeal artery for refractory chronic subdural hematomas.

Authors:  Takao Hashimoto; Tomoo Ohashi; Daisuke Watanabe; Syunichi Koyama; Hiroaki Namatame; Hitoshi Izawa; Rei Haraoka; Hirofumi Okada; Norio Ichimasu; Jiro Akimoto; Jo Haraoka
Journal:  Surg Neurol Int       Date:  2013-08-19

10.  Usefulness of Middle Meningeal Embolization to Prevent Recurrent Spontaneous Chronic Subdural Hemorrhage.

Authors:  Sooji Sirh; Hye Ran Park; Sukh Que Park
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2018-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.